Dr. Natalya Greyz-Yusupov
Claim this profileKaiser Permanente-Fresno
Studies Breast Cancer
Studies Cancer
6 reported clinical trials
11 drugs studied
Area of expertise
1Breast Cancer
Stage I
Stage II
Stage III
2Cancer
ER
PR
HER2/neu
Affiliated Hospitals
Clinical Trials Natalya Greyz-Yusupov is currently running
Symptom Monitoring
for Young Women on Hormone Therapy
This phase III trial compares the effect of active symptom monitoring and patient education to patient education alone in helping young women with stage I-III breast cancer stay on their hormone therapy medicines. The patient education tool contains interactive weblinks which provide patients with education material about breast cancer and side effects of therapy. Symptom monitoring is a weblink via email or text message with questions asking about symptoms. Hormone therapy for breast cancer can cause side effects, and may cause some women to stop treatment early. Asking about symptoms more often may help women keep taking hormone therapy medicines.
Recruiting1 award N/A13 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
More about Natalya Greyz-Yusupov
Clinical Trial Related4 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Natalya Greyz-Yusupov has experience with
- Leucovorin Calcium
- Fluorouracil
- Irinotecan Hydrochloride
- Irinotecan
- Bevacizumab
- Cholecalciferol
Breakdown of trials Natalya Greyz-Yusupov has run
Breast Cancer
Cancer
Colorectal Cancer
Blood Cancers
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Natalya Greyz-Yusupov specialize in?
Natalya Greyz-Yusupov focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage I patients, or patients who are Stage II.
Is Natalya Greyz-Yusupov currently recruiting for clinical trials?
Yes, Natalya Greyz-Yusupov is currently recruiting for 5 clinical trials in Fresno California. If you're interested in participating, you should apply.
Are there any treatments that Natalya Greyz-Yusupov has studied deeply?
Yes, Natalya Greyz-Yusupov has studied treatments such as Leucovorin Calcium, Fluorouracil, Irinotecan Hydrochloride.
What is the best way to schedule an appointment with Natalya Greyz-Yusupov?
Apply for one of the trials that Natalya Greyz-Yusupov is conducting.
What is the office address of Natalya Greyz-Yusupov?
The office of Natalya Greyz-Yusupov is located at: Kaiser Permanente-Fresno, Fresno, California 93720 United States. This is the address for their practice at the Kaiser Permanente-Fresno.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.